Abstract

Rapidly growing and highly vascularized tumors, such as glioblastoma multiforme, contain heterogeneous areas within the tumor mass, some of which are inefficiently supplied with nutrients and oxygen. While the cell death rate is elevated in such zones, tumor cells are still suspected to grow and survive independently of extracellular growth factors. In line with this, glioblastoma stem-like cells (GSCs) are found closely associated with brain vasculature in situ, and as such are most likely in a protected microenvironment. However, the behavior of GSCs under deprived conditions has not been explored in detail. Using a panel of 14 patient-derived GSCs, we report that ex vivo mitogen deprivation impaired self-renewal capability, abolished constitutive activation of the mTor pathway, and impinged on GSC survival via the engagement of autophagic and apoptotic cascades. Moreover, pharmacological inhibition of the mTor pathway recapitulated the mitogen deprivation scenario. In contrast, blocking either apoptosis or autophagy, or culturing GSCs with endothelial-secreted factors partly restored mTor pathway activation and rescued GSC survival. Overall, our data suggest that GSCs are addicted to mTor, as their survival and self-renewal are profoundly dependent on this signaling axis. Thus, as mTor governs the fate of GSCs under both deprivation conditions and in the presence of endothelial factors, it could be a key target for therapeutic purposes.

Highlights

  • Adult glioblastoma multiforme (GBM) is the most common primary brain tumor

  • Number of cells either viable (Annexin V/PI –/–) or in early (Annexin V/PI +/–), late apoptosis (Annexin V/PI +/+) and necrotic (Annexin V/PI –/+) phases was expressed as percentage of total population. g) DNA profile was analyzed by flow cytometry with PI staining in glioblastoma stem-like cells (GSCs)#1

  • It has been described that anti-angiogenic therapies elicit GSC disappearance [9]

Read more

Summary

Introduction

Patients with malignant glioma have poor prognosis due to local recurrence. Radiotherapy and temozolomide chemotherapy, less than 10% of patients reach a 5-year survival [1]. GBMs comprise a subpopulation of cells, which retain the ability to expand ex vivo as neurospheres in mitogen-defined medium and recapitulate tumor formation in mice [2,3]. These so-called glioblastoma stem-like cells (GSCs) share many characteristics with normal stem cells, including selfrenewal and multipotency [3]. Whether apoptosis contributes to limit stem cell expansion has not been completely elucidated. The molecular mechanisms governing the interplay between autophagy and apoptotic cell death in GSCs remain to be elucidated

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.